Lung-CAD

Lung-CAD is a software device that applies deep learning algorithms to adult chest radiographs to identify regions of interest (ROIs) potentially indicative of interstitial thickening. It operates as a concurrent reading aid for physicians by providing DICOM overlays highlighting these ROIs, with studies indicating an enhancement in detection accuracy when the tool is utilized.

Lung-CAD is a computer-assisted detection (CADe) software designed to aid physicians in the interpretation of adult chest radiographs by identifying potential interstitial thickening. The system employs deep learning and computer vision algorithms to analyze digital X-ray images. When a region of interest (ROI) suggestive of interstitial thickening is detected, Lung-CAD generates a DICOM Presentation State file that overlays bounding boxes labeled "Interstitial thickening" on the image within the Picture Archiving and Communication System (PACS) viewer; if no such ROIs are found, the overlay indicates "No Lung-CAD ROI(s)". This functionality is intended to serve as a concurrent reading aid, and the overlay can be toggled by the user, without replacing the physician's role or other diagnostic tests. The device's performance was evaluated through standalone testing and a clinical reader study. Standalone assessment on 5,000 chest radiograph cases showed a sensitivity of 0.913 and specificity of 0.866 in detecting ROIs, with an Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) curve of 0.961. A multiple reader, multiple case (MRMC) retrospective clinical study with 244 cases demonstrated that physicians using Lung-CAD as an aid achieved significantly improved accuracy in detecting interstitial thickening compared to unaided readings, with a mean reader AUC improvement of 0.0797 (p < 0.001).

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the deep learning algorithm in Lung-CAD specifically differentiate interstitial thickening from other common lung parenchymal opacities that might present with similar radiographic features?; What was the demographic and clinical characteristic distribution of the 5,000 cases in the standalone performance assessment, and how does this compare to the 244 cases in the MRMC study?; Given the reported box-level FROC curve, what is the trade-off between sensitivity and false positives per image at the typical operating point, and how might this influence radiologist trust and efficiency?; Does the performance of Lung-CAD (sensitivity, specificity, AUC) vary significantly with different X-ray imaging equipment vendors or acquisition parameters?; What are the specific mechanisms within the 'secure cloud-based processing and delivery' platform that ensure data integrity and patient privacy during image analysis?